AVIR - Atea Pharmaceuticals - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Atea Pharmaceuticals 's activity chart (see below) currently has 13 price targets and 13 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.44% with an average time for these price targets to be met of 83.67 days.

Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 11-Apr-2025. First documented stock forecast 24-Nov-2020.

Matthew Harrison Eric Joseph

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 11-Apr-2025

$0.75 (14.29%)

$6.88

Hold Since 02-Mar-2022

Show more analysts

What is AVIR (Atea Pharmaceuticals ) average time for price targets to be met?

On average it took 83.67 days on average for the stock forecasts to be realized with a an average price target met ratio 64.44

Which analyst has the current highest performing score on AVIR (Atea Pharmaceuticals ) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on AVIR (Atea Pharmaceuticals ) with a proven track record?

ERIC JOSEPH

Which analyst has the most public recommendations on AVIR (Atea Pharmaceuticals )?

Matthew Harrison works at MORGAN STANLEY and has 45 price targets and 29 ratings on AVIR

Which analyst is the currently most bullish on AVIR (Atea Pharmaceuticals )?

Matthew Harrison with highest potential upside - $1.51

Which analyst is the currently most reserved on AVIR (Atea Pharmaceuticals )?

Eric Joseph with lowest potential downside - -$0